Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

prognostic factors

  • Open Access
    Prognostic Factors for Complete Recovery From Xerostomia After Radiotherapy of Head-and-Neck Cancers
    DIRK RADES, BRITTA WARWAS, KARSTEN GERULL, RALPH PRIES, ANKE LEICHTLE, KARL L. BRUCHHAGE, SAMER G. HAKIM, STEVEN E. SCHILD and FLORIAN CREMERS
    In Vivo July 2022, 36 (4) 1795-1800; DOI: https://doi.org/10.21873/invivo.12894
  • Open Access
    Prognostic Factors of Survival After Radiotherapy for Lung Cancer–The Impact of Smoking Pack Years
    ELISA M. WERNER, ESTHER GLATZEL, SABINE BOHNET, STEVEN E. SCHILD and DIRK RADES
    In Vivo May 2022, 36 (3) 1297-1301; DOI: https://doi.org/10.21873/invivo.12830
  • You have access
    Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic Cancer and Brain Involvement
    CARSTEN NIEDER, ASTRID DALHAUG and BÅRD MANNSÅKER
    In Vivo March 2022, 36 (2) 801-805; DOI: https://doi.org/10.21873/invivo.12766
  • You have access
    Stratification of Prognosis by Biological Features Following Neoadjuvant Chemotherapy in Luminal Breast Cancer
    SHINYA YAMAMOTO, TAKASHI CHISHIMA, YUKAKO SHIBATA, SHIORI INOUE, FUMI HARADA, HIDEKI TAKEUCHI, AKIMITSU YAMADA, KAZUTAKA NARUI and ITARU ENDO
    In Vivo March 2022, 36 (2) 859-864; DOI: https://doi.org/10.21873/invivo.12774
  • You have access
    Palliative Radiotherapy for Cutaneous Squamous Cell Carcinoma of the Head-and-Neck Region
    CHRISTIAN STAACKMANN, STEVEN E. SCHILD and DIRK RADES
    In Vivo July 2021, 35 (4) 2283-2288; DOI: https://doi.org/10.21873/invivo.12501
  • You have access
    Clinical Prognostic Factors for Local Control and Survival After Irradiation of Grade II Gliomas
    JASPAR WITTELER, STEVEN E. SCHILD and DIRK RADES
    In Vivo November 2020, 34 (6) 3719-3722; DOI: https://doi.org/10.21873/invivo.12220
  • You have access
    Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib
    NAOKI FUKUDA, KAZUHISA TODA, YU FUJIWARA, XIAOFEI WANG, AKIHIRO OHMOTO, TETSUYA URASAKI, NAOMI HAYASHI, YASUYOSHI SATO, KENJI NAKANO, MAYU YUNOKAWA, MAKIKO ONO, JUNICHI TOMOMATSU, HIROKI MITANI and SHUNJI TAKAHASHI
    In Vivo September 2020, 34 (5) 2859-2864; DOI: https://doi.org/10.21873/invivo.12113
  • You have access
    Increased Expression of p-GSK3β Predicts Poor Survival in T –III/IV Stage OSCC Patients
    BHARATH KUMAR VELMURUGAN, CHUN-WEN CHIU, YUEH-MIN LIN, MAHALAKSHMI BHARATH, CHUNG-MIN YEH, YU-EN CHEN, CHIA-MIN CHUNG and SHU-HUI LIN
    In Vivo July 2020, 34 (4) 1805-1809; DOI: https://doi.org/10.21873/invivo.11975
  • You have access
    Impact of Antiplatelet and Anticoagulant Therapies on Platelet-related Prognostic Markers in Patients With Esophageal Cancer
    YUSUKE ISHIBASHI, HIRONORI TSUJIMOTO, KEITA KOUZU, YUJIRO ITAZAKI, SATOSHI TSUCHIYA, SEIICHIRO FUJISHIMA, YOSHIHISA YAGUCHI, HIDEKAZU SUGASAWA, SHINSUKE NOMURA, NOZOMI ITO, MANABU HARADA, HIROMI NAGATA, EIJI SHINTO, YOJI KISHI and HIDEKI UENO
    In Vivo July 2020, 34 (4) 1941-1949; DOI: https://doi.org/10.21873/invivo.11991
  • You have access
    Eastern Cooperative Oncology Group Performance Score Is Associated With Survival After Radiotherapy of Bone Metastases from Prostate Cancer
    RAPHA HAUS, STEFAN JANSSEN, STEVEN E. SCHILD and DIRK RADES
    In Vivo March 2020, 34 (2) 679-682; DOI: https://doi.org/10.21873/invivo.11823

Pages

  • Next
  • 1
  • 2
In Vivo

© 2022 In Vivo

Powered by HighWire